Short course of Bortezomib in anaemic patients with refractory cold agglutinin disease [Ciclo breve di Bortezomib in pazienti anemici con crioagglutinemia refrattaria]

Trial Profile

Short course of Bortezomib in anaemic patients with refractory cold agglutinin disease [Ciclo breve di Bortezomib in pazienti anemici con crioagglutinemia refrattaria]

Recruiting
Phase of Trial: Phase II

Latest Information Update: 28 Nov 2013

At a glance

  • Drugs Bortezomib (Primary)
  • Indications Autoimmune haemolytic anaemia
  • Focus Therapeutic Use
  • Most Recent Events

    • 28 Nov 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top